Kate E Templeton
Impact in
- Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- SARS-CoV-2 and COVID-19 Research 31
- Antimicrobial Resistance in Staphylococcus 16
- SARS-CoV-2 detection and testing 13
- Epidemiology 58
- Respiratory viral infections research 26
- Co-authors
- Eric C. J. Claas (22 shared papers)Peter Simmonds (21 shared papers)Sitha A. Scheltinga (8 shared papers)Eleanor R. Gaunt (8 shared papers)Alison Hardie (15 shared papers)Heli Harvala (15 shared papers)Matthias F. C. Beersma (3 shared papers)E. Carol McWilliam Leitch (11 shared papers)
- Journals
- Journal of Clinical Microbiology (28 papers)Journal of Clinical Virology (21 papers)Eurosurveillance (10 papers)Journal of Medical Microbiology (8 papers)The Journal of Infectious Diseases (6 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Kate E Templeton
222 papers receiving 13.7k citations
Kate E Templeton's Hit Papers
Peers
Comparison fields: 5 of 155
- Infectious Diseases 7.1k
- Clinical Biochemistry 500
- Epidemiology 3.2k
- Microbiology 622
- Modeling and Simulation 494
Countries citing papers authored by Kate E Templeton
This map shows the geographic impact of Kate E Templeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate E Templeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate E Templeton more than expected).
Fields of papers citing papers by Kate E Templeton
This network shows the impact of papers produced by Kate E Templeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate E Templeton. The network helps show where Kate E Templeton may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate E Templeton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 2 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 3 | 2020 | 756 | |
| 4 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 5 | Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method Hit paper breakdown → | 2010 | 542 |
| 6 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 7 | SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Hit paper breakdown → | 2021 | 465 |
| 8 | 2004 | 398 | |
| 9 | 2004 | 358 | |
| 10 | Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia Hit paper breakdown → | 2016 | 352 |
| 11 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 12 | Late Ebola virus relapse causing meningoencephalitis: a case report Hit paper breakdown → | 2016 | 295 |
| 13 | 2005 | 253 | |
| 14 | 2020 | 240 | |
| 15 | 2015 | 237 | |
| 16 | 2021 | 228 | |
| 17 | 2006 | 203 | |
| 18 | 2008 | 182 | |
| 19 | 2005 | 170 | |
| 20 | 2012 | 161 |
About Kate E Templeton
Kate E Templeton is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Clinical Biochemistry and Hepatology, having authored 225 papers that have together received 14.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (31 papers), Respiratory viral infections research (26 papers), Antimicrobial Resistance in Staphylococcus (16 papers), Viral Infections and Immunology Research (16 papers), SARS-CoV-2 detection and testing (13 papers), Hepatitis C virus research (12 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotic Resistance in Bacteria (11 papers). The work is most often cited by research in Infectious Diseases (7.1k citations), Clinical Biochemistry (500 citations), Epidemiology (3.2k citations), Microbiology (622 citations) and Modeling and Simulation (494 citations). Kate E Templeton has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Eric C. J. Claas, Peter Simmonds, Sitha A. Scheltinga, Eleanor R. Gaunt, Alison Hardie, Heli Harvala, Matthias F. C. Beersma, E. Carol McWilliam Leitch, Naomi J. Gadsby and Aloys C.M. Kroes. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Clinical Virology, Eurosurveillance, Journal of Medical Microbiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.